In 2015, we distributed 24,815,155 cycles of oral contraceptives (OCs). This prevented 564,951 disability-adjusted life years (DALYs), provided 1,654,344 couple years of protection (CYPs) , and prevented 377,954 unintended pregnancies. We began socially marketing oral contraceptives in Bangladesh in 1976, and currently work with oral contraceptives in 25 countries.
The key to a successful family planning program lies in offering a wide range of contraceptive options to meet the diverse needs and wishes of clients. Oral contraceptives are a popular method among women and couples around the world. They are a highly effective, reversible and safe method of preventing unintended pregnancy.
There are two types of oral contraceptives:
- Combined oral contraceptives contain low doses of two synthetic hormones, estrogen and progestin, which simulate the natural hormones estrogen and progesterone. They work primarily by preventing the release of eggs from the ovaries (ovulation). Combined oral contraceptives are also called “the pill,” low-dose combined pills, oral contraceptive pills (OCPs) and OCs.
- Progestin-only pills contain very low doses of progestin and do not contain estrogen. For this reason, they provide a suitable option for women throughout breastfeeding and can be used by women who cannot use methods with estrogen. They work primarily by thickening cervical mucus (this blocks sperm from meeting an egg) and can prevent ovulation. Progestin-only pills are also called “mini pills” or progestin-only oral contraceptives.
PSI’s marketing strategies for oral contraceptives help inform consumers to create demand by addressing the key barriers that prevent women from using oral contraceptives. We then work with providers in the following ways to meet demand with quality products and services:
- Ensuring that health service providers at all relevant levels are knowledgeable about the full range of contraceptive options and are able to present them within the context of informed choice. Service providers can include doctors, nurses, midwives, community health workers and pharmacists. They are often the first points of contact for clients interested in learning about family planning.
- Training service providers in family planning counseling and method administration, including community-based distribution of oral contraceptives and other short-acting methods as authorized by local health authorities.
- Deploying medical detailers to visit service providers at their workplaces to learn what information and support they need to offer a broad method mix.
Making a Difference
Given the low cost to produce oral contraceptives and the well established market for these products, PSI is exploring opportunities for the development and introduction of more affordable oral contraceptive brands. PSI is currently launching a third generation oral contraceptive called Meuri in countries like Haiti and Angola, among others.
- Triggerise 2017 Annual Report
In October 2017, Triggerise developed a 3-year strategic plan, clearly articulating its vision, objectives and key results. By the end of 2020, Triggerise will have delivered cost efficient wealth and health impact to more than 1 million people. This annual report highlights the funding received from its largest donor – the Ministry of Foreign Affairs of the Netherlands, in partnership with PSI via project ignite – along with other new strategic donors investing in Triggerise’ development and impact.
- Ignite 2017 Annual Report
Project ignite looks further at the total market – informed by rigorous market assessments – and the various actors influencing the end user – to improve and correct underperforming aspects of the market and access to contraception and safe abortion services. This is the 2017 Annual Report that summarizes the key findings, successes, and lessons learned from PSI’s country operations in Haiti, Mozambique, and Cote d’Ivoire, as well as Triggerise’s innovations testing in India and Kenya.
- Ignite and Triggerise: 2017 Analytics and Insights
This report was shared at the ignite project meeting held in The Hague in October 2017, highlighting Triggerise’ progress to date with ignite and brand redesign activities following market research insights.
- Ignite and Triggerise: 2016 Annual Report
Triggerise’s 2016 Annual Report, sharing insights and results across all of its major donor-funded projects, including PSI/Dutch-funded project ignite.
- Ignite and PSI Mozambique’s TEM+ Escolas: Bringing Contraceptive Counseling and Product Delivery to Schools
In Mozambique, PSI’s network of Tem+ clinics are delivering contraceptive counseling and products directly to schools, challenging negative attitudes towards youth access to SRH services while simultaneously creating a positive enabling environment at the service delivery level.
- Didier Playbook
This resource provides guidance for live prototyping a social media-led approach that initiates dialogue on sexuality and gender equity with the target audience in Abidjan.
- Adolescents 360: A Girl with a Plan!
Adolescents 360 aims to increase the demand for, uptake of and perception surrounding voluntary, modern contraceptives among adolescent girls in Nigeria, Tanzania and Ethiopia. This two-pager dives into the program’s unique Human-Centered Design approach to drive adolescent and youth sexual and reproductive health breakthrough.
- Niger Male Segmentation Analysis
Quantitative analysis of men’s attitudes and behaviors related to contraception and family planning leading to behavioral/-attitudinal segmentation in Niger
- Transform/PHARE Project Fact Sheet
Project fact sheet for Transform/PHARE